Cargando…
Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)
BACKGROUND: Francisella tularensis subspecies tularensis is the causative agent of a spectrum of diseases collectively known as tularemia. An attenuated live vaccine strain (LVS) has been shown to be efficacious in humans, but safety concerns have prevented its licensure by the FDA. Recently, F. tul...
Autores principales: | Twine, Susan M., Petit, Mireille D., Fulton, Kelly M., House, Robert V., Conlan, J. Wayne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848853/ https://www.ncbi.nlm.nih.gov/pubmed/20368994 http://dx.doi.org/10.1371/journal.pone.0010000 |
Ejemplares similares
-
A ΔclpB Mutant of Francisella tularensis Subspecies holarctica Strain, FSC200, Is a More Effective Live Vaccine than F. tularensis LVS in a Mouse Respiratory Challenge Model of Tularemia
por: Golovliov, Igor, et al.
Publicado: (2013) -
A Mucosal Subunit Vaccine Protects against Lethal Respiratory Infection with Francisella tularensis LVS
por: Ashtekar, Amit R., et al.
Publicado: (2012) -
The Reduced Genome of the Francisella tularensis Live Vaccine Strain (LVS) Encodes Two Iron Acquisition Systems Essential for Optimal Growth and Virulence
por: Pérez, Natalie Marie, et al.
Publicado: (2014) -
Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections
por: Robinson, Cory M, et al.
Publicado: (2015) -
The capBCA Locus is Required for Intracellular Growth of Francisella tularensis LVS
por: Su, Jingliang, et al.
Publicado: (2011)